trending Market Intelligence /marketintelligence/en/news-insights/trending/uogclqddc4m1zrlf1vym2q2 content esgSubNav
In This List

MiMedx gets another Nasdaq noncompliance notice

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


MiMedx gets another Nasdaq noncompliance notice

MiMedx Group Inc. received another noncompliance notice from the Nasdaq stock market for failing to file a periodic report.

The Marietta, Ga.-based company is yet to file its quarterly earnings report for the three months ended March 31.

MiMedx previously received a Nasdaq notice for failing to file its annual report for the year ended Dec. 31, 2017. The company, which develops regenerative biomaterial products and bioimplants, has submitted to Nasdaq a plan to regain compliance.

The Nasdaq notice has no immediate effect on the listing of the company's common stock.